Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Gene Editing Market Growth in 2025?

The size of the gene editing market has seen swift expansion in the past few years. Expected to surge from a valuation of $8.82 billion in 2024 to around $10.34 billion in 2025, the sector is set to experience a compound annual growth rate (CAGR) of 17.3%. Factors such as the discovery of CRISPR-Cas9, improvements in genetic sequencing, medical advancements, allocation of funds for scientific research, and growth in the biotechnology industry are responsible for the historical growth of this market.

What Is the Forecast for the Gene Editing Market Size Through 2029?

Over the coming years, anticipations are high for a swift expansion in the gene editing market size. The market is projected to soar to $20.79 billion by 2029, boasting a compound annual growth rate (CAGR) of 19.1%. The predicted growth in this period can be tied to an expansion in therapeutic applications, improvements in precision and efficiency, the commercialization of gene therapy, development in agricultural applications and growth in regenerative medicine. Major trends to look out for within this forecast period encompass multiplex editing techniques, innovations in base editing, alterations in gene drives and population, non-viral delivery systems, as well as advancements in disease modeling and drug discovery.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

What are the Key Market Players in Gene Editing Market and How They’re Evolving?

Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

What Are the Primary Growth Drivers in the Gene Editing Market?

The rise in communicable diseases is driving the gene editing market forward, accentuating the importance of gene editing methods for the diagnosis and treatment of these diseases. These diseases, caused by infectious agents such as bacteria, viruses, or parasites, can be transferred between individuals, animals, or even the environment. Gene editing tools are being progressively utilized to devise targeted strategies that can detect and counteract pathogens at a genetic level, thus improving initiatives for disease control and prevention. According to the World Economic Forum, a Switzerland-based international NGO, there has been an uptick in infections such as influenza and respiratory syncytial virus (RSV) since the pandemic year of 2023. In the same year, the USA reported approximately 24 million influenza cases, 260,000 hospitalizations and 16,000 deaths as of February 2023. Furthermore, in 2022, the World Health Organization stated that globally, 10.6 million individuals had been infected with tuberculosis, with tuberculosis-related deaths reaching 1.3 million. Consequently, the prevalence of communicable diseases is augmenting the gene editing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp

What Are the Leading Segments in the Global Gene Editing Industry?

The gene editing market covered in this report is segmented –

1) By Technology: CRISPR, TALEN, ZFN

2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering

3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

Subsegments:

1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives

2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits

3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits

What Are the Key Market Trends in the Gene Editing Industry?

Top firms in the gene editing industry are unveiling cutting-edge technology in their field, including a method inspired by unique cell-penetrating peptides. This technique not only offers benefits over the existing methodologies but could also pave the way for the creation of advanced cellular treatments for cancer and other diseases. An example of this comes from Penn Medicine, a prestigious multi-hospital health system in the United States, which discovered in April 2023 that protein snippets employed by certain viruses to infiltrate cells can also be employed to deliver CRISPR-Cas gene editing molecules into cells and their DNA-storage nuclei with amazing efficiency and minimal cellular toxicity. Researchers anticipate this new technique to be highly beneficial for altering T cells and other cells collected from a patient to produce cellular therapies. One potential application could be CAR T (chimeric antigen receptor T cell) therapy, which uses bespoke immune cells from a patient to combat cancer. This fresh approach to cell genetic engineering offers substantial enhancements in speed, efficiency, and a decrease in cellular toxicity compared to traditional techniques.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

What Is the Regional Outlook for the Gene Editing Market?

North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2486

This Report Delivers Insight On:

1. How big is the gene editing market, and how is it changing globally?

2. Who are the major companies in the gene editing market, and how are they performing?

3. What are the key opportunities and risks in the gene editing market right now?

4. Which products or customer segments are growing the most in the gene editing market?

5. What factors are helping or slowing down the growth of the gene editing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model